Home parenteral lipids in AIDS: A three-month study

Pierre Singer, Ray Levine, Michael Rothkopf, Jeffrey Askanazi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Parenteral nutrition is a part of the nutritional support regimen of patients with AIDS-associated wasting syndrome and gastrointestinal dysfunction. The cholesterol (CHOL) level in human immunodeficiency virus (HIV) membrane is very high, and recent lipid formulations with high phospholipid (PL) content have demonstrated the ability to trap CHOL from endogenous sources, modifying the composition of cell membranes. We administered lipid-based home parenteral nutrition for 3 mo to malnourished AIDS patients. The patients were randomly divided into two groups: 23 received the regular 20% fat emulsion formulation, and 27 received a 2% formulation enriched 10-fold with PLs but containing the same amount of triglycerides. All patients gained weight and improved their activity level. Those receiving the high-PL composition showed increased serum CHOL concentrations (from 147 to 241 mg/dL; P < 0.01), but no increase was seen in the number of CD4 cells or improvement in immune function. HIV infectivity was not modified. Patients receiving regular PLs had significantly decreased (P < 0.02) IgA concentrations (from 776 to 300 mg/dL) and improved mitogen response to phytohemagglutinin and to concanavalin A. This formula, too, had no effect on HIV infectivity. We conclude that standard parenteral nutrition influences the nutritional and immune status of malnourished AIDS patients. A PL-enriched parenteral formulation can trap CHOL, but it does not affect the immune profile or HIV infectivity in patients with advanced disease.

Original languageEnglish (US)
Pages (from-to)104-109
Number of pages6
JournalNutrition
Volume13
Issue number2
DOIs
StatePublished - Feb 1 1997
Externally publishedYes

Fingerprint

Acquired Immunodeficiency Syndrome
Lipids
Cholesterol
HIV
Phospholipids
Parenteral Nutrition
HIV Wasting Syndrome
Home Parenteral Nutrition
Nutritional Support
Phytohemagglutinins
Concanavalin A
Emulsions
Nutritional Status
Mitogens
Immunoglobulin A
Triglycerides
Cell Count
Fats
Cell Membrane
Weights and Measures

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Singer, Pierre ; Levine, Ray ; Rothkopf, Michael ; Askanazi, Jeffrey. / Home parenteral lipids in AIDS : A three-month study. In: Nutrition. 1997 ; Vol. 13, No. 2. pp. 104-109.
@article{2354a39e01b54dfba0f89dd5c996492b,
title = "Home parenteral lipids in AIDS: A three-month study",
abstract = "Parenteral nutrition is a part of the nutritional support regimen of patients with AIDS-associated wasting syndrome and gastrointestinal dysfunction. The cholesterol (CHOL) level in human immunodeficiency virus (HIV) membrane is very high, and recent lipid formulations with high phospholipid (PL) content have demonstrated the ability to trap CHOL from endogenous sources, modifying the composition of cell membranes. We administered lipid-based home parenteral nutrition for 3 mo to malnourished AIDS patients. The patients were randomly divided into two groups: 23 received the regular 20{\%} fat emulsion formulation, and 27 received a 2{\%} formulation enriched 10-fold with PLs but containing the same amount of triglycerides. All patients gained weight and improved their activity level. Those receiving the high-PL composition showed increased serum CHOL concentrations (from 147 to 241 mg/dL; P < 0.01), but no increase was seen in the number of CD4 cells or improvement in immune function. HIV infectivity was not modified. Patients receiving regular PLs had significantly decreased (P < 0.02) IgA concentrations (from 776 to 300 mg/dL) and improved mitogen response to phytohemagglutinin and to concanavalin A. This formula, too, had no effect on HIV infectivity. We conclude that standard parenteral nutrition influences the nutritional and immune status of malnourished AIDS patients. A PL-enriched parenteral formulation can trap CHOL, but it does not affect the immune profile or HIV infectivity in patients with advanced disease.",
author = "Pierre Singer and Ray Levine and Michael Rothkopf and Jeffrey Askanazi",
year = "1997",
month = "2",
day = "1",
doi = "10.1016/S0899-9007(96)00383-8",
language = "English (US)",
volume = "13",
pages = "104--109",
journal = "Nutrition",
issn = "0899-9007",
publisher = "Elsevier Inc.",
number = "2",

}

Home parenteral lipids in AIDS : A three-month study. / Singer, Pierre; Levine, Ray; Rothkopf, Michael; Askanazi, Jeffrey.

In: Nutrition, Vol. 13, No. 2, 01.02.1997, p. 104-109.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Home parenteral lipids in AIDS

T2 - A three-month study

AU - Singer, Pierre

AU - Levine, Ray

AU - Rothkopf, Michael

AU - Askanazi, Jeffrey

PY - 1997/2/1

Y1 - 1997/2/1

N2 - Parenteral nutrition is a part of the nutritional support regimen of patients with AIDS-associated wasting syndrome and gastrointestinal dysfunction. The cholesterol (CHOL) level in human immunodeficiency virus (HIV) membrane is very high, and recent lipid formulations with high phospholipid (PL) content have demonstrated the ability to trap CHOL from endogenous sources, modifying the composition of cell membranes. We administered lipid-based home parenteral nutrition for 3 mo to malnourished AIDS patients. The patients were randomly divided into two groups: 23 received the regular 20% fat emulsion formulation, and 27 received a 2% formulation enriched 10-fold with PLs but containing the same amount of triglycerides. All patients gained weight and improved their activity level. Those receiving the high-PL composition showed increased serum CHOL concentrations (from 147 to 241 mg/dL; P < 0.01), but no increase was seen in the number of CD4 cells or improvement in immune function. HIV infectivity was not modified. Patients receiving regular PLs had significantly decreased (P < 0.02) IgA concentrations (from 776 to 300 mg/dL) and improved mitogen response to phytohemagglutinin and to concanavalin A. This formula, too, had no effect on HIV infectivity. We conclude that standard parenteral nutrition influences the nutritional and immune status of malnourished AIDS patients. A PL-enriched parenteral formulation can trap CHOL, but it does not affect the immune profile or HIV infectivity in patients with advanced disease.

AB - Parenteral nutrition is a part of the nutritional support regimen of patients with AIDS-associated wasting syndrome and gastrointestinal dysfunction. The cholesterol (CHOL) level in human immunodeficiency virus (HIV) membrane is very high, and recent lipid formulations with high phospholipid (PL) content have demonstrated the ability to trap CHOL from endogenous sources, modifying the composition of cell membranes. We administered lipid-based home parenteral nutrition for 3 mo to malnourished AIDS patients. The patients were randomly divided into two groups: 23 received the regular 20% fat emulsion formulation, and 27 received a 2% formulation enriched 10-fold with PLs but containing the same amount of triglycerides. All patients gained weight and improved their activity level. Those receiving the high-PL composition showed increased serum CHOL concentrations (from 147 to 241 mg/dL; P < 0.01), but no increase was seen in the number of CD4 cells or improvement in immune function. HIV infectivity was not modified. Patients receiving regular PLs had significantly decreased (P < 0.02) IgA concentrations (from 776 to 300 mg/dL) and improved mitogen response to phytohemagglutinin and to concanavalin A. This formula, too, had no effect on HIV infectivity. We conclude that standard parenteral nutrition influences the nutritional and immune status of malnourished AIDS patients. A PL-enriched parenteral formulation can trap CHOL, but it does not affect the immune profile or HIV infectivity in patients with advanced disease.

UR - http://www.scopus.com/inward/record.url?scp=0031080702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031080702&partnerID=8YFLogxK

U2 - 10.1016/S0899-9007(96)00383-8

DO - 10.1016/S0899-9007(96)00383-8

M3 - Article

C2 - 9106787

AN - SCOPUS:0031080702

VL - 13

SP - 104

EP - 109

JO - Nutrition

JF - Nutrition

SN - 0899-9007

IS - 2

ER -